112 related articles for article (PubMed ID: 19947919)
1. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
[TBL] [Abstract][Full Text] [Related]
2. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
Smith PC; Cáceres M; Martinez J
J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
[TBL] [Abstract][Full Text] [Related]
3. Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium.
Lee J; Ko M; Joo CK
J Cell Physiol; 2008 Aug; 216(2):520-6. PubMed ID: 18314880
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 (TGF-beta1) and acetylcholine (ACh) alter nitric oxide (NO) and interleukin-1beta (IL-1beta) secretion in human colon adenocarcinoma cells.
Paduch R; Kandefer-Szerszeń M
In Vitro Cell Dev Biol Anim; 2009 Oct; 45(9):543-50. PubMed ID: 19551451
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.
Tian YC; Chen YC; Chang CT; Hung CC; Wu MS; Phillips A; Yang CW
Exp Cell Res; 2007 Jul; 313(11):2367-77. PubMed ID: 17467690
[TBL] [Abstract][Full Text] [Related]
6. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.
Sinpitaksakul SN; Pimkhaokham A; Sanchavanakit N; Pavasant P
Biochem Biophys Res Commun; 2008 Jul; 371(4):713-8. PubMed ID: 18457660
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3.
Konrad L; Scheiber JA; Schwarz L; Schrader AJ; Hofmann R
Regul Pept; 2009 Jun; 155(1-3):28-32. PubMed ID: 19422858
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
10. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
11. [The effect of RhoA/Rho kinase signal pathway on TGF-beta1-induced phenotypic differentiation of human dermal fibroblasts].
Hu YL; Liu Z; Jiao DK; Ma T; Wang CY; Jia CY
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):376-80. PubMed ID: 22259991
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.
De Wever O; Nguyen QD; Van Hoorde L; Bracke M; Bruyneel E; Gespach C; Mareel M
FASEB J; 2004 Jun; 18(9):1016-8. PubMed ID: 15059978
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
14. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
15. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
16. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
[TBL] [Abstract][Full Text] [Related]
17. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Mol Cancer Res; 2008 Oct; 6(10):1607-20. PubMed ID: 18922976
[TBL] [Abstract][Full Text] [Related]
18. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
19. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
20. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
